Date: Nov 26, 2013 Source: xConomy (
click here to go to the source)
Date 11/26/2013
Company Name Ancera
Mailing Address 21 Business Park Drive Branford, CT 06405
Company Description The company is developing a rapid, portable technology platform for the separation, quantitative detection and identification of minute concentrations of various pathogens from whole blood or other bodily fluids. Ancera's platform is based on technology it is licensing exclusively from Yale University. The technology uses magnetic fields to manipulate biologic cells via a ferromagnetic fluid.
Website http://www.anceradx.com
Transaction Type Debt
Transaction Amount $1,277,500
Transaction Round Undisclosed
Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
Venture Investor Undisclosed
